Title:
COMPOSITION FOR PREVENTING OR TREATING PROSTATIC HYPERPLASIA COMPRISING MIXED EXTRACTS OF CURCUMAE RADIX AND SYZYGII FLOS
Document Type and Number:
WIPO Patent Application WO/2020/149694
Kind Code:
A2
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating prostatic hyperplasia, comprising mixed extracts of Curcumae Radix and Syzygii Flos as an effective component. The mixed extracts were found to inhibit the expression of dihydrotestosterone, androgen receptors, prostate-specific antigens, proliferating cell nuclear antigen (PCNA), cyclin B1, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB); and to have less adverse side effects compared to an existing prostatic hyperplasia drug, finasteride, and thus may be beneficially used for the prevention or treatment of prostatic hyperplasia.
More Like This:
Inventors:
UM JAE-YOUNG (KR)
JUNG YUN-U (KR)
PARK JIN-BONG (KR)
YOUN DONG-HYUN (KR)
LEE BEOM-SU (KR)
JUNG YUN-U (KR)
PARK JIN-BONG (KR)
YOUN DONG-HYUN (KR)
LEE BEOM-SU (KR)
Application Number:
PCT/KR2020/000857
Publication Date:
July 23, 2020
Filing Date:
January 17, 2020
Export Citation:
Assignee:
UNIV INDUSTRY COOPERATION GROUP KYUNG HEE UNIV (KR)
International Classes:
A61K36/9066; A23L33/105; A61K36/61; A61P13/08
Attorney, Agent or Firm:
WIE, Byoung-Gap (KR)
Download PDF:
Previous Patent: RUTHENIUM COMPLEX COMPOUND, LIGAND FOR PRODUCING SAME, AND USE THEREOF
Next Patent: ELECTROMECHANICAL BRAKE SYSTEM
Next Patent: ELECTROMECHANICAL BRAKE SYSTEM